Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Overview
Date Founded

2000

Headquarters

16 Xingguo Road,Xiuying District,Haikou, Hainan 570314

Type of Company

Public

Employees (Worldwide)

353

Industries

Pharmaceuticals

Company Description

Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of chemically synthesized peptide drugs. It offers finished dosages and generic peptide active pharmaceutical ingredients. The company was founded on May 22, 2000 and is headquartered in Haikou, China.

Contact Data
Trying to get in touch with decision makers at Hainan Shuangcheng Pharmaceuticals Co., Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Executive Deputy General Manager

Chief Financial Officer

General Manager

Director & Deputy General Manager

Board Secretary & Deputy General Manager

Deputy General Manager, Vice President & Core Technical Staff

Deputy General Manager of Peptide API

Vice Chairman

Marketing Director

Associate Quality Director

Board of Directors

General Manager at Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Vice Chairman at Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Senior Scientist at Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Director & Deputy General Manager at Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Independent Director at Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Paths to Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Potential Connections via
Relationship Science
You
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Recent Transactions
Details Hidden

Hangzhou Aopeng Investment Management Co., Ltd. purchases Hangzhou Ausia Biological Technology Co., Ltd. from Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Details Hidden

Hainan Shuangcheng Pharmaceuticals Co., Ltd. purchases Hangzhou Ausia Biological Technology Co., Ltd. from Zhejiang Juke Industrial Co., Ltd.

Details Hidden

Hainan Shuangcheng Pharmaceuticals Co., Ltd. purchases Bendalis GmbH

Transaction Advisors
Underwriter

Advised onHainan Shuangcheng Pharmaceuticals Co., Ltd. issued CNY Common Stock

Clients

Frontier Biotechnologies, Inc. engages in the research and development, production, and sale of medicines. Its products include anti-human immunodeficiency virus treatment and pain treatment. The company was founded by Dong Xie, Chang Jin Wang and Rong Jian Lu on January 15, 2013 and is headquartered in Nanjing, China.

Key Stats and Financials As of 2019
Market Capitalization
$230M
Total Enterprise Value
$305M
Earnings Per Share
$0.01
EBITDAMargin
3.85%
Enterprise Value / Sales
6.17x
Enterprise Value EBITDAOperating
160.33x
TEVNet Income
84.8x
Debt TEV
0.08x
Three Year Compounded Annual Growth Rate Of Revenue
33.71%
Five Year Compounded Annual Growth Rate Of Revenue
16.22%
Revenue
$49.3M
Net Profit
$3.59M
EBITDA
$1.9M
Total Debt
$24.3M
Total Equity
$98.8M
Investors
Details Hidden

IDG-CP is a venture capital investment firm focused on high-technology sectors such as Internet applications and services, telecommunications, wireless communications, digital media, electronics, systems integration, semiconductors and integrated circuits. Although Internet and telecom value-added services are their long-term focus, the firm considers opportunistic investment across industries, for example in financial services, radio and broadcasting and in the service industry. They also invest in sectors such as artistic content, nutrition and healthcare, education and environmental sustainability.IDG-CP invests in startups and expansion-stage companies primarily in China, and specializes in the early identification of highly successful IT businesses. Investment decisions are based on in-depth market research and technology analysis. The firm's investment approach leverages IDG's global capabilities as well as a well-established network of Chinese entrepreneurs. Their chief investment criteria are the quality of the management team and an indication of future profitability in a high-growth sector. They favor businesses with a competitive edge based on proprietary technology, and benefiting from protected distribution channels.IDG-CP generally invests between USD 500 thousand and 5 million, and may invest follow-on capital once success is established. The firm provides extensive support services to their investee companies, including strategic advisory, market research, senior personnel training, organizational consulting and legal counsel. They also provide a range of services to foreign companies seeking to enter the Chinese market. IDG-CP's exit strategies include IPOs, mergers and trade sales.

Details Hidden

Seavi Advent invests in range of US$10 million to US$25 million for growth stage and matured companies seeking later stage funding in sectors of business services, specialty retailing & healthcare services, chemicals, telecoms & information technology, environmental engineering, clean energy. The firm is open to syndicating with other investors for investments of larger amounts such as for buyout and control transactions. They act as lead investor and plays an active role on the boards of portfolio companies.

Suppliers
Chongqing Sansheng Industrial Co., Ltd. Chemicals | Chongqing, China

Chongqing Sansheng Industrial Co., Ltd. engages in the production and sale of building materials and pharmaceutical products. It operates through Building Materials & Chemicals Segment and Pharmaceutical Manufacturing Segment. The Building Materials & Chemicals Segment specializes in the production and sale of building materials and chemical products, such as commercial concrete, water reducing agent, expansion agent, and sulfuric acid, while the Pharmaceutical Manufacturing Segment engages in the production of pharmaceutical intermediates, raw materials, and preparation products. The company was founded in 1995 and is headquartered in Chongqing, China.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hainan Shuangcheng Pharmaceuticals Co., Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Hainan Shuangcheng Pharmaceuticals Co., Ltd..